Biosynthesis and Regulation of Sulfomenaquinone, a Metabolite Associated with Virulence in Mycobacterium tuberculosis.

Sulfomenaquinone (SMK) is a recently identified metabolite that is unique to the Mycobacterium tuberculosis (M. tuberculosis) complex and is shown to modulate its virulence. Here, we report the identification of the SMK biosynthetic operon that, in addition to a previously identified sulfotransferase stf3, includes a putative cytochrome P450 gene (cyp128) and a gene of unknown function, rv2269c. We demonstrate that cyp128 and stf3 are sufficient for the biosynthesis of SMK from menaquinone and rv2269c exhibits promoter activity in M. tuberculosis. Loss of Stf3 expression, but not that of Cyp128, is correlated with elevated levels of menaquinone-9, an essential component in the electron-transport chain in M. tuberculosis. Finally, we showed in a mouse model of infection that the loss of cyp128 exhibits a hypervirulent phenotype similar to that in previous studies of the stf3 mutant. These findings provide a platform for defining the molecular basis of SMK's role in M. tuberculosis pathogenesis.

[1]  M. Chase,et al.  Leaderless Transcripts and Small Proteins Are Common Features of the Mycobacterial Translational Landscape , 2015, PLoS genetics.

[2]  A. Upadhyay,et al.  Partial Saturation of Menaquinone in Mycobacterium tuberculosis: Function and Essentiality of a Novel Reductase, MenJ , 2015, ACS central science.

[3]  D. Tobin,et al.  Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids , 2013, Nature.

[4]  David G. Russell,et al.  Intracellular Mycobacterium tuberculosis Exploits Host-derived Fatty Acids to Limit Metabolic Stress* , 2013, The Journal of Biological Chemistry.

[5]  B. Gicquel,et al.  High Throughput Phenotypic Selection of Mycobacterium tuberculosis Mutants with Impaired Resistance to Reactive Oxygen Species Identifies Genes Important for Intracellular Growth , 2013, PloS one.

[6]  C. Bertozzi,et al.  Sulfolipid-1 Biosynthesis Restricts Mycobacterium tuberculosis Growth in Human Macrophages , 2012, ACS chemical biology.

[7]  C. Bertozzi,et al.  Cholesterol catabolism by Mycobacterium tuberculosis requires transcriptional and metabolic adaptations. , 2012, Chemistry & biology.

[8]  D. Nomura,et al.  Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation , 2011, Science.

[9]  M. Voskuil,et al.  DosS Responds to a Reduced Electron Transport System To Induce the Mycobacterium tuberculosis DosR Regulon , 2010, Journal of bacteriology.

[10]  P. Ortiz de Montellano,et al.  Biochemical and structural characterization of CYP124: A methyl-branched lipid ω-hydroxylase from Mycobacterium tuberculosis , 2009, Proceedings of the National Academy of Sciences.

[11]  J. C. Hinshaw,et al.  Menaquinone synthesis is critical for maintaining mycobacterial viability during exponential growth and recovery from non‐replicating persistence , 2009, Molecular microbiology.

[12]  C. Bertozzi,et al.  Structural characterization of a novel sulfated menaquinone produced by stf3 from Mycobacterium tuberculosis. , 2008, ACS chemical biology.

[13]  G. Bancroft,et al.  The case for hypervirulence through gene deletion in Mycobacterium tuberculosis. , 2008, Trends in microbiology.

[14]  Christopher J Petzold,et al.  Lipidomics reveals control of Mycobacterium tuberculosis virulence lipids via metabolic coupling , 2007, Proceedings of the National Academy of Sciences.

[15]  C. Bertozzi,et al.  A sulfated metabolite produced by stf3 negatively regulates the virulence of Mycobacterium tuberculosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Chi‐Huey Wong,et al.  Sulfotransferases: structure, mechanism, biological activity, inhibition, and synthetic utility. , 2004, Angewandte Chemie.

[17]  Spencer J. Williams,et al.  Discovery of sulfated metabolites in mycobacteria with a genetic and mass spectrometric approach , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Glickman,et al.  A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. , 2000, Molecular cell.

[19]  Chu-Wei Kuo,et al.  Altered Expression Profile of the Surface Glycopeptidolipids in Drug-resistant Clinical Isolates of Mycobacterium aviumComplex* , 1999, The Journal of Biological Chemistry.

[20]  B. Barrell,et al.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.

[21]  W. Jacobs,et al.  New use of BCG for recombinant vaccines , 1991, Nature.

[22]  Philippe Roche,et al.  Symbiotic host-specificity of Rhizobium meliloti is determined by a sulphated and acylated glucosamine oligosaccharide signal , 1990, Nature.

[23]  M. Collins,et al.  Distribution of menaquinones in actinomycetes and corynebacteria. , 1977, Journal of general microbiology.

[24]  J. Armstrong,et al.  Prevention of phagosome-lysosome fusion in cultured macrophages by sulfatides of Mycobacterium tuberculosis. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Goren.  Sulfolipid I of Mycobacterium tuberculosis, strain H37Rv. I. Purification and properties. , 1970, Biochimica et biophysica acta.

[26]  J. Cox,et al.  Host-pathogen interactions during Mycobacterium tuberculosis infections. , 2013, Current topics in microbiology and immunology.

[27]  R. Devés,et al.  Restoration of active transport of solutes and oxidative phosphorylation by naphthoquinones in irradiated membrane vesicles from Mycobacterium phlei. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[28]  B. Arison,et al.  Characterization of vitamin K9(H) from Mycobacterium phlei. , 1963, Biochemistry.